Bone disseminated breast cancer cells secrete osteolytic factors like PTHrP, which induces receptor activator of nuclear factor-κB ligand (RANKL)-dependent osteoclastogenesis through PTH1R activation on osteoblasts [30]. The gene discussed is PTH1R; the disease is breast carcinoma.